NCT04877379 - VNRX-7145 Drug-Drug Interaction in Healthy Adult Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 8, 2021

Primary Completion Date

November 10, 2021

Study Completion Date

November 10, 2021

Conditions

Healthy Subjects

Interventions

DRUG

VNRX-7145

β-lactamase inhibitor

DRUG

VNRX-5024 (ceftibuten)

β-lactam antibiotic

DRUG

Placebo

Trial Locations (1)

PRA Health Sciences - Early Development Services, Groningen

All Listed Sponsors

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Venatorx Pharmaceuticals, Inc.

INDUSTRY